Chapter title |
High Content Screening of Mammalian Primary Cortical Neurons
|
---|---|
Chapter number | 17 |
Book title |
High Content Screening
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7357-6_17 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7355-2, 978-1-4939-7357-6
|
Authors |
Dario Motti, Murray Blackmore, John L. Bixby, Vance P. Lemmon |
Abstract |
High Content Screening (HCS) can be used to analyze the morphology of neuronal primary cultures on a large scale. When used in the field of neuronal regeneration this approach allows the screening of hundreds or thousands of perturbagens, such as miRNAs, cDNAs, or compounds, for their ability to induce neuronal growth. One of the most important steps while designing these kinds of experiments is the choice of the correct neuronal model. Testing the correct neuronal type is critical to obtain results that are biologically significant and that can later be translated to a clinical setting. For example, if the goal is identifying possible therapies for Spinal Cord Injury (SCI), a challenging target is the neuronal projection from the motor cortex to the spinal cord, the corticospinal tract. Here, we describe the experimental protocols that can be used to produce primary cortical culture from young rat cortices, electroporate the neurons to study the effect of altered gene expression on neurite growth, and immunostain to measure neurite growth parameters. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 2 | 50% |
Student > Doctoral Student | 1 | 25% |
Student > Postgraduate | 1 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Nursing and Health Professions | 2 | 50% |
Biochemistry, Genetics and Molecular Biology | 1 | 25% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 25% |